Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Hepatitis Therapeutics Global Market Report 2024
... ProvidersCovering: Gilead Sciences Inc.; Bristol-Myers Squibb Co.; AbbVie Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc. Hepatitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Research Report 2024(Status and Outlook)
... performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Hepatitis B Vaccines market covering ... Read More
-
Global Hepatitis A Vaccination Market Research Report 2024(Status and Outlook)
... HAV infection, Minimum age for HAV vaccination is 1 year. The Global Hepatitis A Vaccination Market Size was estimated at USD 754.91 million in 2023 and is projected to reach USD 860.20 million by 2029, ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
... 2028 The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. ... Read More
-
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The global human ... Read More
-
Liver Disease Diagnostics Market Forecasts to 2030 – Global Analysis By Disease Type (Viral Hepatitis, Alcoholic Liver Disease, Non-alcoholic Fatty Liver Disease (NAFLD), Liver Cancer and Other Disease Types), Technique (Endoscopy, Biopsy, Imaging Techniques, Laboratory Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography
... Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography According to Stratistics MRC, the Global Liver Disease Diagnostics Market is accounted for $40.32 billion in 2023 and ... Read More
-
Hepatitis B - Global Clinical Trials Review, 2023
... B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Hepatitis Drugs Global Market Report 2024
... 2) By Route Of Administration: Oral; Injection3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 4) By Application: Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis ECovering: Gilead Sciences Inc.; F. Hoffmann-La Roche ... Read More
-
Interferons Market Forecasts to 2030 – Global Analysis By Product (Interferon Gamma, Interferon Beta, Interferon Alpha and Other Products), Application (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Hepatitis B, Melanoma, Leukemia, AIDS, Kaposi Sarcoma, Renal Cell Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography
... Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography According to Stratistics MRC, the Global Interferons Market is ... Read More
-
Diagnostic Specialty Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Dengue Diagnostics, HIV Diagnostics, Hepatitis Diagnosis, Infectious Disease Diagnostics, Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition
... Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition Global Diagnostic Specialty Antibodies Market is anticipated to project impressive growth in the forecast period. The Global Diagnostic Specialty Antibodies ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... liver. It is spread through contact with an infected person's blood or bodily fluids. Sexual contact, sharing needles or other drug injection equipment, or being exposed to blood or body fluids in a healthcare setting ... Read More
-
Hepatitis B Vaccine Market Report and Forecast 2024-2032
... size is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032 to achieve a value of USD 7.3 billion by 2032. Hepatitis B Vaccine: Introduction The Hepatitis B vaccine is ... Read More
-
Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032
... across the 7MM since many people go undiagnosed. In 2022, the market size of Chronic Hepatitis B was highest in the US among the 7MM accounting for approximately USD 1,500 million, is expected to increase ... Read More
-
Latin America Vaccine Market Report and Forecast 2023-2028
... by the support of the rising awareness about immunisation and the growing application of vaccines in various healthcare settings, the market is projected to further grow at a CAGR of 7.10% between 2023 and 2028 ... Read More
-
Hyperimmune Globulins Market Forecasts to 2030 – Global Analysis By Type (Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Rho(D) Immunoglobulins, Tetanus Immunoglobulins and Other Types), By End User (Hospitals & Clinics, Blood Banks and Donation Centers, Government Institutions and Other End Users) and By Geography
... Institutions and Other End Users) and By Geography According to Stratistics MRC, the Global Hyperimmune Globulins Market is accounted for $2.01 billion in 2023 and is expected to reach $3.69 billion by 2030 growing at ... Read More
-
Hepatitis B Treatment Market – Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Type (Acute, Chronic), By Treatment (Immune modulator Drugs, Antiviral Drugs, Vaccines, Surgery), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition
... Online Pharmacies), By Region, Competition Global Hepatitis B Treatment Market is anticipated to project steady growth in the forecast period. The Global Hepatitis B Treatment Market is a dynamic sector within the broader pharmaceutical and ... Read More
-
United States Diagnostics Market By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable, Disposable), By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19}, Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Usability (Reusable, Disposable), By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19}, Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), ... Read More
-
Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type (Blood Tests {By Blood Tests {Liver Function Tests, Immunoassays, Nucleic Acid Tests}, Imaging Test, Liver Biopsy), By Region and Competition
... exhibit impressive growth during the forecast period, maintaining a Compound Annual Growth Rate (CAGR) of 8.14% through 2028. The global healthcare industry has undergone a significant transformation, primarily driven by technological advancements and an increasing ... Read More
-
Infectious Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Service (Assays, Kits, & Reagents, Instruments, Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others), By End User (Hospital and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others), By Region and Competition
... an anticipated Compound Annual Growth Rate (CAGR) of 4.89% through 2028. Losartan is a medication primarily prescribed for the treatment of high blood pressure (hypertension) and specific heart conditions. It falls under the category of ... Read More
-
Travel Vaccines Global Market Report 2023 Including: 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; 2) By Composition: Mono Vaccines; Combination Vaccines 3) By Booking Channel: Online Booking; In-Person Booking 4) By Application: Domestic Travel; Outbound Travel Covering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
... Channel: Online Booking; In-Person Booking4) By Application: Domestic Travel; Outbound TravelCovering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA Travel Vaccines Global Market Report 2023 from The Business Research Company ... Read More
Research Assistance
